Sprout Capital Healthcare Technology Portfolio Performance Summary
Sprout Capital Healthcare Technology Portfolio Performance Summary The passage provides internal performance metrics for a venture capital fund with no mention of influential public officials, controversial actions, or financial flows tied to power centers. It lacks actionable leads for investigative follow‑up. Key insights: Sprout Funds invested $1.019 billion in 69 healthcare tech companies (1995‑2013).; Generated $1.997 billion in realized returns plus $68 million unrealized.; Reported IRR outperformance versus major public indices (e.g., +638 bps vs S&P 500 for Sprout IX).
Summary
Sprout Capital Healthcare Technology Portfolio Performance Summary The passage provides internal performance metrics for a venture capital fund with no mention of influential public officials, controversial actions, or financial flows tied to power centers. It lacks actionable leads for investigative follow‑up. Key insights: Sprout Funds invested $1.019 billion in 69 healthcare tech companies (1995‑2013).; Generated $1.997 billion in realized returns plus $68 million unrealized.; Reported IRR outperformance versus major public indices (e.g., +638 bps vs S&P 500 for Sprout IX).
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.